Suxamethonium induced prolonged apnea in a patient receiving electroconvulsive therapy

General Hospital Psychiatry
Avinash WaghmareJagadisha Thirthalli

Abstract

Suxamethonium causes prolonged apnea in patients in whom pseudocholinesterase enzyme gets deactivated by organophosphorus (OP) poisons. Here, we present a similar incident in a severely depressed patient who received electroconvulsive therapy (ECT). Prolonged apnea in our case ensued because the information about suicidal attempt by OP compound was concealed from the treating team.

References

Aug 1, 1988·British Journal of Anaesthesia·F Pérez GuillermoC J Vidal
Dec 22, 2006·Clinica Chimica Acta; International Journal of Clinical Chemistry·Indumathi ManoharanOksana Lockridge
Sep 7, 2007·The Journal of ECT·Joseph WilliamsW Vaughn McCall
Jul 17, 2010·General Hospital Psychiatry·Avinash WaghmareJagadisha Thirthalli

❮ Previous
Next ❯

Citations

Nov 8, 2011·Annals of General Psychiatry·Maxim Zavorotnyy, Peter Zwanzger
Sep 19, 2012·Indian Journal of Psychiatry·Chittaranjan AndradeE Mohandas
Nov 19, 2011·Acta Anaesthesiologica Scandinavica·H MirzakhaniA Nozari
Jun 27, 2015·Pharmacogenomics·Hooman MirzakhaniHenk-Jan Guchelaar
Oct 7, 2015·The Journal of ECT·Samuel BulteauAnne Sauvaget
Aug 16, 2016·The Psychiatric Clinics of North America·Chittaranjan AndradeJagadisha Thirthalli
Jul 17, 2010·General Hospital Psychiatry·Avinash WaghmareJagadisha Thirthalli
Mar 12, 2021·BMC Psychiatry·Shibu Sasidharan, Harpreet Singh Dhillon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Catatonic Schizophrenia

Catatonia is a psychomotor symptom in which patients present with stupor, although catatonic excitement may also present at the other end of the spectrum. Catatonia has been historically associated with schizophrenia although it is also associated with other neuropsychiatric disorders. Find the latest research on catatonic schizophrenia here.